UK 370753

Drug Profile

UK 370753

Latest Information Update: 15 Dec 2003

Price : $50

At a glance

  • Originator Pfizer
  • Class Antifungals
  • Mechanism of Action Myristoyl transferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Aspergillosis; Candidiasis

Most Recent Events

  • 15 Dec 2003 No development reported - Preclinical for Candidiasis in United Kingdom (unspecified route)
  • 15 Dec 2003 No development reported - Preclinical for Aspergillosis in United Kingdom (unspecified route)
  • 27 Apr 2001 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top